ホーム › アトピー性皮膚炎（湿疹） › ジョージア州
ジョージア州におけるアトピー性皮膚炎（湿疹）の臨床試験
ジョージア州内の拠点で、アトピー性皮膚炎（湿疹）に関する9件の研究が参加者を募集しています。
ジョージア州内の都市
公式研究テキスト（英語）
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- Skin Care Physicians of Georgia - Macon- Site Number : 8400034, Macon
被験者募集中観察研究
12歳以上 · 全性別 · 2026/09/29更新 · NCT07290803Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Atlanta
- Novartis Investigative Site, Macon
被験者募集中第2相
18歳〜100歳 · 全性別 · 2026/09/28更新 · NCT06947993Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Atlanta
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Douglasville
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07003425A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- Hamilton Research, LLC, Alpharetta
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07223697A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Georgia Skin & Cancer Center, Savannah
被験者募集中第2相
18歳〜65歳 · 全性別 · 2026/08/28更新 · NCT07599813A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Emory University School Of Medicine - Atlanta /ID# 268832, Atlanta
- Aeroallergy Research Laboratory /ID# 267247, Savannah
被験者募集中第3相
2歳〜11歳 · 全性別 · 2026/08/06更新 · NCT06461897A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Macon
被験者募集中第3相
6 Months – 11 Years · 全性別 · 2026/07/07更新 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Centricity Research Columbus Dermatology /ID# 266529, Columbus
- Cleaver Medical Group Dermatology /ID# 263788, Dawsonville
被験者募集中第3相
18歳〜63歳 · 全性別 · 2026/07/06更新 · NCT06389136ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。